ArticleFrontiers in psychiatry2021

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1.

Mara Parellada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.